|
Topical steroids are contraindicated for patients
with a hypersensitivity to any of the components. Systemic
absorption of topical corticosteroids has produced
reversible hypothalamic-pituitary-adrenal (HPA) axis
suppression, manifestation of Cushing's syndrome,
hyperglycemia, and glucosuria in some patients. Patients
receiving a large dose of a potent topical steroid applied
to a large area or under an occlusive dressing should be
periodically evaluated. Pediatric safety and effectiveness
have not been established.
|